RBL2 and cancer: Nevertheless, investigation of RB, p130, and p107 control of cell cycle gene expression in the context of other oncogenic mutations could provide significant insight into how cell cycle progression is regulated in cancer cells treated with DNA damaging chemotherapeutics.